News |
Shore Capital appointed as Joint Broker to Eagle Eye Solutions Group Plc
Shore Capital is delighted to have been appointed as Joint Broker to Eagle Eye Solutions Group Plc, with a […]
SCGL Share option exercise period extension
21 December 2018 Shore Capital Group Limited, the independent investment group specialising in capital markets, asset management and principal […]
News |
WPP restructuring must gain traction before stock valued higher, says Roddy Davidson
Roddy Davidson, media analyst at Shore Capital, discusses the announcement that WPP will cut 3,500 jobs in a $382 million […]
SCGL Result of Annual General Meeting 2018
11 December 2018 Shore Capital Group Limited – Result of Annual General Meeting Shore Capital Group Limited, the independent […]
News |
Shore Capital acted as Nomad and Joint Bookrunner, raising £19m for Inspired Energy
7 December 2018 Inspired Energy plc (“Inspired”, or the “Company”) Completion £19.0 million Placing for the Company Posting of […]
News |
Shore Capital appointed as Nomad and Sole Broker to Titon Holdings Plc
Shore Capital has been appointed as Nominated Adviser and Sole Broker to Titon Holdings plc with effect […]
SCGL – Puma Property Finance secures £200m funding line
Shore Capital Group Limited (“Shore Capital” or the “Company”) – Puma Property Finance secures £200m institutional funding commitment Shore […]
Posting of Notice of AGM
Shore Capital Group Limited Posting of Notice of AGM Shore Capital Group Limited (the “Company”), the independent investment group […]
News |
Shore Capital acted as Joint Global Coordinator on the secondary placing of 4 million shares in Global Ports Holding Plc
GLOBAL PORTS HOLDING PLC (“GPH PLC” or the “Company”) Results of secondary placing of ordinary shares in GPH […]
News |
Deal of the Year (£10m to £50m) – Shore Capital acted as Financial and Rule 3 Adviser to Styles & Wood Group plc
Deal of the Year (£10m to £50m) Last night was the North West Dealmakers Awards 2018, held in Manchester. […]
News |
Life Science Analysis: RNA therapeutics are now a clinical reality
After nearly two decades in development, RNA therapeutics are now a clinical reality. Shore Capital’s Healthcare Analyst, Tara Raveendran, discusses […]
News |
Shore Capital appointed as Joint Broker to Marks & Spencer plc
Shore Capital is delighted to have been appointed as Joint Broker to the FTSE 100 retailer, Marks & Spencer […]
News |
Shore Capital sponsors ‘AIM Transaction of the Year’ at the AIM Awards 2018
Shore Capital is proud to have been one of the sponsors at this year’s prestigious AIM Awards 2018. As a […]
News |
Shore Capital acted as Nomad, Sole Bookrunner and Broker, raising £3m for Sosandar
10 October 2018 Sosandar plc – Placing to raise £3.0 million Sosandar PLC (AIM: SOS), the online women’s […]
News |
Shore Capital is proud to be sponsoring the 3rd Annual Capital Markets Conference in Tel Aviv
Shore Capital is proud to be sponsoring the 3rd Annual Capital Markets Conference taking place in Tel Aviv on 13 […]
SCGL Performance of Funds – August 2018
The following table gives the performance for the month ended 31 August 2018 of the funds managed by the Group’s […]
News |
Shore Capital acted as Nomad, Global Co-ordinator & Bookrunner raising €175m for Applegreen
Applegreen plc (“Applegreen” or the “Company” or, together with its subsidiaries, the “Group”) Placing Raising €175 million (c. £156m) […]
Shore Capital acted as Nomad, Global Co-ordinator & Bookrunner raising €175m for Applegreen RNS
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED […]
